Kjersti Flatmark

6.3k total citations · 1 hit paper
146 papers, 4.3k citations indexed

About

Kjersti Flatmark is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Kjersti Flatmark has authored 146 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Oncology, 53 papers in Surgery and 45 papers in Molecular Biology. Recurrent topics in Kjersti Flatmark's work include Colorectal Cancer Treatments and Studies (30 papers), Intraperitoneal and Appendiceal Malignancies (28 papers) and Colorectal Cancer Surgical Treatments (24 papers). Kjersti Flatmark is often cited by papers focused on Colorectal Cancer Treatments and Studies (30 papers), Intraperitoneal and Appendiceal Malignancies (28 papers) and Colorectal Cancer Surgical Treatments (24 papers). Kjersti Flatmark collaborates with scholars based in Norway, United States and United Kingdom. Kjersti Flatmark's co-authors include Øystein Fodstad, Kjetil Boye, Anne Hansen Ree, Gunhild M. Mælandsmo, Svein Dueland, Kristina Schee, Eivind Hovig, Stein Gunnar Larsen, Bastian Fromm and Therese Seierstad and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kjersti Flatmark

144 papers receiving 4.2k citations

Hit Papers

Laparoscopic Versus Open Resection for Colorectal Liver M... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kjersti Flatmark Norway 34 1.9k 1.6k 1.4k 1.0k 560 146 4.3k
Yasushi Ichikawa Japan 43 1.4k 0.7× 2.4k 1.5× 1.0k 0.7× 1.3k 1.3× 1.0k 1.8× 247 5.0k
Haeryoung Kim South Korea 37 1.4k 0.8× 1.8k 1.1× 1.1k 0.8× 1.6k 1.5× 761 1.4× 226 5.7k
Emmanuelle Leteurtre France 42 1.6k 0.9× 1.1k 0.7× 793 0.6× 2.5k 2.5× 721 1.3× 172 6.3k
Rondell P. Graham United States 34 1.3k 0.7× 2.2k 1.4× 930 0.7× 1.8k 1.8× 1.2k 2.2× 227 5.0k
Fritz Wrba Austria 38 1.2k 0.6× 1.6k 1.0× 545 0.4× 1.3k 1.3× 985 1.8× 167 4.7k
Takayuki Ueno Japan 33 1.4k 0.7× 1.7k 1.0× 996 0.7× 533 0.5× 671 1.2× 186 3.9k
Aatur D. Singhi United States 43 1.7k 0.9× 3.9k 2.5× 1.3k 0.9× 2.3k 2.3× 1.1k 1.9× 225 6.8k
Yutaka Midorikawa Japan 31 1.7k 0.9× 689 0.4× 729 0.5× 625 0.6× 388 0.7× 110 3.4k
Benny Vittrup Jensen Denmark 34 1.4k 0.8× 2.9k 1.9× 1.2k 0.9× 681 0.7× 917 1.6× 123 4.8k
Chanjuan Shi United States 40 1.7k 0.9× 4.3k 2.7× 911 0.7× 1.3k 1.3× 550 1.0× 167 6.7k

Countries citing papers authored by Kjersti Flatmark

Since Specialization
Citations

This map shows the geographic impact of Kjersti Flatmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjersti Flatmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjersti Flatmark more than expected).

Fields of papers citing papers by Kjersti Flatmark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjersti Flatmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjersti Flatmark. The network helps show where Kjersti Flatmark may publish in the future.

Co-authorship network of co-authors of Kjersti Flatmark

This figure shows the co-authorship network connecting the top 25 collaborators of Kjersti Flatmark. A scholar is included among the top collaborators of Kjersti Flatmark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjersti Flatmark. Kjersti Flatmark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lund‐Andersen, Christin, Chakravarthi Kanduri, Vegar Johansen Dagenborg, et al.. (2024). Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. Journal of Translational Medicine. 22(1). 646–646. 4 indexed citations
2.
Høye, Eirik, Chakravarthi Kanduri, Susanne Lorenz, et al.. (2024). Enrichment of Cancer‐Associated Fibroblasts, Macrophages, and Up‐Regulated TNF ‐α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis. Cancer Medicine. 14(1). e70521–e70521. 1 indexed citations
3.
Ito, Ichiaki, Abdelrahman Yousef, Saikat Chowdhury, et al.. (2023). Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma. Cancer Research. 83(19). 3184–3191. 4 indexed citations
4.
Spasojevic, Milan, Lars Julsrud, Henrik M. Reims, et al.. (2023). ASO Visual Abstract: Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer. Annals of Surgical Oncology. 30(12). 7637–7638. 1 indexed citations
5.
Høye, Eirik, Bastian Fromm, P. H. Michael Böttger, et al.. (2022). A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer. NAR Cancer. 4(1). zcab051–zcab051. 9 indexed citations
6.
Meltzer, Sebastian, Anne Negård, Hanne Hamre, et al.. (2022). Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer. British Journal of Cancer. 127(12). 2227–2233. 5 indexed citations
7.
Lund‐Andersen, Christin, et al.. (2021). Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review. Journal of Gastrointestinal Oncology. 12(S1). S191–S203. 17 indexed citations
8.
Ree, Anne Hansen, Vigdis Nygaard, Hege G. Russnes, et al.. (2019). Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain. Cancer Immunology Research. 7(5). 701–706. 5 indexed citations
9.
Fromm, Bastian, Diana Domańska, Eirik Høye, et al.. (2019). MirGeneDB 2.0: the metazoan microRNA complement. Nucleic Acids Research. 48(D1). D132–D141. 179 indexed citations
10.
Meltzer, Sebastian, Anne Negård, Kjersti Flatmark, et al.. (2019). Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?. Clinical and Translational Radiation Oncology. 21. 5–10. 8 indexed citations
11.
Andersson, Yvonne, Stein Gunnar Larsen, Ben Davidson, et al.. (2019). ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis. European Journal of Surgical Oncology. 47(1). 134–138. 20 indexed citations
12.
Fußer, Markus, Anders Øverbye, Abhilash Pandya, et al.. (2018). Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. Journal of Controlled Release. 293. 183–192. 43 indexed citations
13.
Goscinski, Mariusz Adam, et al.. (2016). Fibromatosis in vertical rectus abdominis myocutaneous flap imitating tumor recurrence after surgery for locally advanced rectal cancer: case report. World Journal of Surgical Oncology. 14(1). 63–63. 2 indexed citations
14.
Kalanxhi, Erta, Svein Dueland, Solveig Norheim Andersen, et al.. (2016). Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy. Cancer Research and Treatment. 49(2). 374–386. 4 indexed citations
15.
Fretland, Åsmund Avdem, Airazat М. Kazaryan, Bjørn Atle Bjørnbeth, et al.. (2016). Open versus laparoscopic liver resection of colorectal metastases: The Oslo-CoMet study. HPB. 18. e59–e60. 7 indexed citations
16.
Thorgersen, Ebbe Billmann, Mariusz Adam Goscinski, Milan Spasojevic, et al.. (2016). Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer. Annals of Surgical Oncology. 24(3). 721–728. 10 indexed citations
17.
Wiiger, Merete Thune, et al.. (2014). The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells. Journal of Ovarian Research. 7(1). 23–23. 9 indexed citations
18.
Boye, Kjetil, et al.. (2012). B7‐H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer. International Journal of Cancer. 131(11). 2528–2536. 104 indexed citations
19.
Boye, Kjetil, Jahn M. Nesland, Berit Sandstad, Gunhild M. Mælandsmo, & Kjersti Flatmark. (2010). Nuclear S100A4 is a novel prognostic marker in colorectal cancer. European Journal of Cancer. 46(16). 2919–2925. 40 indexed citations
20.
Nguyen, Mai T., et al.. (2009). Different Expression and Clinical Role of S100A4 in Serous Ovarian Carcinoma at Different Anatomic Sites. Tumor Biology. 30(1). 15–25. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026